InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Segal Jeffrey, Director. Director active across 1 company, notably INVO Bioscience, Inc.. In total, 3 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 15 January 2022. The latest transaction was disclosed on 1 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations3 total
9,211 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015908:0
Ideal exit: 26 Feb 2023 (T+270)
8,034 shares0Common StockSEC:0001493152-22-001534
8,034 shares0Common StockSEC:0001493152-22-001534:0
3 of 3 declarations
About Segal Jeffrey
Jeffrey Segal is a Director at INVO Bioscience, Inc. As a board member, he contributes to the governance and strategy of the company. His experience in the biotechnology sector allows him to provide valuable insights into the development of new treatments.
